Elevation Oncology Analyst Ratings
BenzingaApr 9 06:20 ET
Promising Preclinical Data and Positive Phase 2 Results Bolster Buy Rating for Elevation Oncology
TipRanksApr 9 06:17 ET
Analysts Offer Insights on Healthcare Companies: Adaptimmune Therapeutics (ADAP), Elevation Oncology (ELEV) and AC Immune SA (ACIU)
TipRanksMar 11 01:00 ET
Elevation Oncology (ELEV) Receives a Buy From TD Cowen
TipRanksMar 7 14:25 ET
Elevation Oncology Analyst Ratings
BenzingaMar 7 07:39 ET
Analysts Offer Insights on Healthcare Companies: Elevation Oncology (ELEV) and OrthoPediatrics (KIDS)
TipRanksMar 7 00:30 ET
Elevation Oncology Analyst Ratings
BenzingaMar 1 11:35 ET
Optimistic Buy Rating for Elevation Oncology on EO-3021's Promising Clinical Advancements and Differentiation
TipRanksMar 1 00:25 ET
Elevation Oncology Analyst Ratings
BenzingaFeb 20 07:53 ET
Wedbush Reiterates Outperform on Elevation Oncology, Maintains $5 Price Target
BenzingaNov 6, 2023 10:20 ET
Elevation Oncology Analyst Ratings
BenzingaNov 6, 2023 10:19 ET
Elevation Oncology's Robust Financial Position and Promising Clinical Trial Data Drive Buy Rating
TipRanksNov 6, 2023 00:58 ET
Buy Rating on Elevation Oncology's Stock Supported by EO-3021 Clinical Program Progress and Potential Cash Boost
TipRanksNov 3, 2023 06:38 ET
Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM), Sotera Health (SHC) and Elevation Oncology (ELEV)
TipRanksNov 2, 2023 12:32 ET
Elevation Oncology Analyst Ratings
BenzingaSep 29, 2023 07:35 ET
Wedbush Trims Elevation Oncology's Price Target to $5 From $6, Keeps Outperform Rating
MT NewswiresAug 4, 2023 07:22 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevation Oncology (ELEV), Novartis AG (Six Swiss: CH:NOVN) and VBI Vaccines (VBIV)
TipRanksJul 19, 2023 05:04 ET
Wedbush Maintains Outperform on Elevation Oncology, Raises Price Target to $6
BenzingaJun 5, 2023 08:17 ET
Wedbush Lifts Elevation Oncology's Price Target to $6 From $4 on 'Impressive' Data, Keeps Outperform Rating
MT NewswiresJun 5, 2023 07:24 ET
SVB Securities Upgrades Elevation Oncology to Outperform, Raises Price Target to $8
BenzingaMay 30, 2023 06:59 ET
No Data
No Data